Evaluation of an Oral Nutritional Supplement
This study has been completed.
Information provided by (Responsible Party):
First received: January 31, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
The objective of this study is to evaluate gastrointestinal tolerance of an oral nutritional supplement containing a new protein blend in healthy elderly subjects.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
|Official Title:||Evaluation of an Oral Nutritional Supplement With a New Protein Blend|
Resource links provided by NLM:
Further study details as provided by Abbott Nutrition:
Primary Outcome Measures:
- Gastro-Intestinal Tolerance [ Time Frame: Study Day 1-7 ] [ Designated as safety issue: No ]Self-reported questionnaire
Secondary Outcome Measures:
- Study Product Compliance [ Time Frame: Study Day 1-7 ] [ Designated as safety issue: No ]Self-reported number of containers consumed per day
- Weight [ Time Frame: Study Day 1 and 8 ] [ Designated as safety issue: No ]
|Study Start Date:||October 2012|
|Study Completion Date:||November 2012|
|Primary Completion Date:||November 2012 (Final data collection date for primary outcome measure)|
Experimental: Study Oral Nutritional Supplement
2 containers a day of a high calorie, complete, balanced, ready-to-drink oral nutritional supplement with a new protein blend.
Other: Study Oral Nutritional Supplement
Supplement contains a new protein mix consisting of a blend of milk, soy, and pea protein.
Contacts and Locations